Colorectal cancer patient characteristics, treatment and survival in Oman - A single center study

Shiyam Kumar, Ikram A. Burney, Khawaja Farhan Zahid, Philomena Charlotte D Souza, Muna Al Belushi, Taha Dawood Mufti, Waeil Al Meki, Muhammad Furrukh, Mansour S. Al Moundhri

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Colorectal cancer is the most common gastrointestinal cancer in Oman with an increasing incidence. We here report the presenting features, treatment outcomes and survival in a University hospital in Oman and compare our data with regional and international studies. Materials and Methods: Medical records of patients with colorectal cancer were reviewed retrospectively between June 2000 and December 2013 and were followed until June 2014. Results: A total of 162 patients were diagnosed with colorectal cancer. The majority were males (58.6%), with a median age of 56 years. Rectum was involved in 29.6% of patients, followed by ascending and sigmoid colon. The majority of patients had stage III (42.6%) and stage IV (32.7%) disease at presentation. K-Ras status was checked for 79 patients, and 41 (51.9%) featured the wild type. Median relapse free survival was 22 months. Median overall survival for all patients was 43 months. Observed 5 year overall survival (OS) for stages I, II and III was 100%, 60% and 60% respectively. On Log rank univariate analysis, age, BMI, diabetes, hypertension, metformin use, stage, clinical nodal status for rectal cancer, pathological T and nodal status, site of metastasis, surgical intervention, chemotherapy, radiotherapy, chemotherapy regimen, no of cycles of chemotherapy, response, RFS, site of recurrence and administration of 2nd line chemotherapy were significant factors affecting OS. On Cox regression multivariate analysis none of the factors independently affected the OS. Conclusions: The majority of patients present with advanced disease and at young age. The survival rates are comparable to the published regional and international literature.

Original languageEnglish
Pages (from-to)4853-4858
Number of pages6
JournalAsian Pacific Journal of Cancer Prevention
Volume16
Issue number12
DOIs
Publication statusPublished - 2015

Fingerprint

Oman
Colorectal Neoplasms
Survival
Drug Therapy
Therapeutics
Ascending Colon
Recurrence
Gastrointestinal Neoplasms
Metformin
Sigmoid Colon
Rectal Neoplasms
Rectum
Medical Records
Radiotherapy
Multivariate Analysis
Survival Rate
Regression Analysis
Neoplasm Metastasis
Hypertension
Incidence

Keywords

  • Chemotherapy
  • Colon cancer
  • Metastasis
  • Oman
  • Recurrence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Colorectal cancer patient characteristics, treatment and survival in Oman - A single center study. / Kumar, Shiyam; Burney, Ikram A.; Zahid, Khawaja Farhan; Souza, Philomena Charlotte D; Al Belushi, Muna; Mufti, Taha Dawood; Al Meki, Waeil; Furrukh, Muhammad; Al Moundhri, Mansour S.

In: Asian Pacific Journal of Cancer Prevention, Vol. 16, No. 12, 2015, p. 4853-4858.

Research output: Contribution to journalArticle

Kumar, Shiyam ; Burney, Ikram A. ; Zahid, Khawaja Farhan ; Souza, Philomena Charlotte D ; Al Belushi, Muna ; Mufti, Taha Dawood ; Al Meki, Waeil ; Furrukh, Muhammad ; Al Moundhri, Mansour S. / Colorectal cancer patient characteristics, treatment and survival in Oman - A single center study. In: Asian Pacific Journal of Cancer Prevention. 2015 ; Vol. 16, No. 12. pp. 4853-4858.
@article{c74af12a88d547f284177d938ccc2cf9,
title = "Colorectal cancer patient characteristics, treatment and survival in Oman - A single center study",
abstract = "Background: Colorectal cancer is the most common gastrointestinal cancer in Oman with an increasing incidence. We here report the presenting features, treatment outcomes and survival in a University hospital in Oman and compare our data with regional and international studies. Materials and Methods: Medical records of patients with colorectal cancer were reviewed retrospectively between June 2000 and December 2013 and were followed until June 2014. Results: A total of 162 patients were diagnosed with colorectal cancer. The majority were males (58.6{\%}), with a median age of 56 years. Rectum was involved in 29.6{\%} of patients, followed by ascending and sigmoid colon. The majority of patients had stage III (42.6{\%}) and stage IV (32.7{\%}) disease at presentation. K-Ras status was checked for 79 patients, and 41 (51.9{\%}) featured the wild type. Median relapse free survival was 22 months. Median overall survival for all patients was 43 months. Observed 5 year overall survival (OS) for stages I, II and III was 100{\%}, 60{\%} and 60{\%} respectively. On Log rank univariate analysis, age, BMI, diabetes, hypertension, metformin use, stage, clinical nodal status for rectal cancer, pathological T and nodal status, site of metastasis, surgical intervention, chemotherapy, radiotherapy, chemotherapy regimen, no of cycles of chemotherapy, response, RFS, site of recurrence and administration of 2nd line chemotherapy were significant factors affecting OS. On Cox regression multivariate analysis none of the factors independently affected the OS. Conclusions: The majority of patients present with advanced disease and at young age. The survival rates are comparable to the published regional and international literature.",
keywords = "Chemotherapy, Colon cancer, Metastasis, Oman, Recurrence",
author = "Shiyam Kumar and Burney, {Ikram A.} and Zahid, {Khawaja Farhan} and Souza, {Philomena Charlotte D} and {Al Belushi}, Muna and Mufti, {Taha Dawood} and {Al Meki}, Waeil and Muhammad Furrukh and {Al Moundhri}, {Mansour S.}",
year = "2015",
doi = "10.7314/APJCP.2015.16.12.4853",
language = "English",
volume = "16",
pages = "4853--4858",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "12",

}

TY - JOUR

T1 - Colorectal cancer patient characteristics, treatment and survival in Oman - A single center study

AU - Kumar, Shiyam

AU - Burney, Ikram A.

AU - Zahid, Khawaja Farhan

AU - Souza, Philomena Charlotte D

AU - Al Belushi, Muna

AU - Mufti, Taha Dawood

AU - Al Meki, Waeil

AU - Furrukh, Muhammad

AU - Al Moundhri, Mansour S.

PY - 2015

Y1 - 2015

N2 - Background: Colorectal cancer is the most common gastrointestinal cancer in Oman with an increasing incidence. We here report the presenting features, treatment outcomes and survival in a University hospital in Oman and compare our data with regional and international studies. Materials and Methods: Medical records of patients with colorectal cancer were reviewed retrospectively between June 2000 and December 2013 and were followed until June 2014. Results: A total of 162 patients were diagnosed with colorectal cancer. The majority were males (58.6%), with a median age of 56 years. Rectum was involved in 29.6% of patients, followed by ascending and sigmoid colon. The majority of patients had stage III (42.6%) and stage IV (32.7%) disease at presentation. K-Ras status was checked for 79 patients, and 41 (51.9%) featured the wild type. Median relapse free survival was 22 months. Median overall survival for all patients was 43 months. Observed 5 year overall survival (OS) for stages I, II and III was 100%, 60% and 60% respectively. On Log rank univariate analysis, age, BMI, diabetes, hypertension, metformin use, stage, clinical nodal status for rectal cancer, pathological T and nodal status, site of metastasis, surgical intervention, chemotherapy, radiotherapy, chemotherapy regimen, no of cycles of chemotherapy, response, RFS, site of recurrence and administration of 2nd line chemotherapy were significant factors affecting OS. On Cox regression multivariate analysis none of the factors independently affected the OS. Conclusions: The majority of patients present with advanced disease and at young age. The survival rates are comparable to the published regional and international literature.

AB - Background: Colorectal cancer is the most common gastrointestinal cancer in Oman with an increasing incidence. We here report the presenting features, treatment outcomes and survival in a University hospital in Oman and compare our data with regional and international studies. Materials and Methods: Medical records of patients with colorectal cancer were reviewed retrospectively between June 2000 and December 2013 and were followed until June 2014. Results: A total of 162 patients were diagnosed with colorectal cancer. The majority were males (58.6%), with a median age of 56 years. Rectum was involved in 29.6% of patients, followed by ascending and sigmoid colon. The majority of patients had stage III (42.6%) and stage IV (32.7%) disease at presentation. K-Ras status was checked for 79 patients, and 41 (51.9%) featured the wild type. Median relapse free survival was 22 months. Median overall survival for all patients was 43 months. Observed 5 year overall survival (OS) for stages I, II and III was 100%, 60% and 60% respectively. On Log rank univariate analysis, age, BMI, diabetes, hypertension, metformin use, stage, clinical nodal status for rectal cancer, pathological T and nodal status, site of metastasis, surgical intervention, chemotherapy, radiotherapy, chemotherapy regimen, no of cycles of chemotherapy, response, RFS, site of recurrence and administration of 2nd line chemotherapy were significant factors affecting OS. On Cox regression multivariate analysis none of the factors independently affected the OS. Conclusions: The majority of patients present with advanced disease and at young age. The survival rates are comparable to the published regional and international literature.

KW - Chemotherapy

KW - Colon cancer

KW - Metastasis

KW - Oman

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=84937043842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937043842&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2015.16.12.4853

DO - 10.7314/APJCP.2015.16.12.4853

M3 - Article

VL - 16

SP - 4853

EP - 4858

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 12

ER -